I. Barazer

1.0k total citations
8 papers, 331 citations indexed

About

I. Barazer is a scholar working on Cardiology and Cardiovascular Medicine, Internal Medicine and Surgery. According to data from OpenAlex, I. Barazer has authored 8 papers receiving a total of 331 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Cardiology and Cardiovascular Medicine, 3 papers in Internal Medicine and 2 papers in Surgery. Recurrent topics in I. Barazer's work include Antiplatelet Therapy and Cardiovascular Diseases (4 papers), Venous Thromboembolism Diagnosis and Management (3 papers) and Heart Failure Treatment and Management (3 papers). I. Barazer is often cited by papers focused on Antiplatelet Therapy and Cardiovascular Diseases (4 papers), Venous Thromboembolism Diagnosis and Management (3 papers) and Heart Failure Treatment and Management (3 papers). I. Barazer collaborates with scholars based in France and Switzerland. I. Barazer's co-authors include Jean‐Luc Reny, Philippe Berdagué, Pierre Fontana, Pascale Fabbro-Péray, François Mach, Henri Bounameaux, Séverine Nolli, Philippe de Moerloose, Jean‐François Schved and Nora Mallouk and has published in prestigious journals such as Circulation, American Heart Journal and Journal of Thrombosis and Haemostasis.

In The Last Decade

I. Barazer

8 papers receiving 324 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
I. Barazer France	7	290	104	74	43	32	8	331
Teresa Lozano Spain	10	169 0.6×	95 0.9×	36 0.5×	14 0.3×	46 1.4×	39	392
Viviana Aursulesei Romania	9	150 0.5×	65 0.6×	53 0.7×	8 0.2×	54 1.7×	52	324
Vanessa Gallois France	6	366 1.3×	152 1.5×	192 2.6×	25 0.6×	15 0.5×	7	401
Koon-Hou Mak United States	8	360 1.2×	287 2.8×	144 1.9×	84 2.0×	25 0.8×	11	487
Tomohiro Fujisaki United States	9	189 0.7×	104 1.0×	43 0.6×	12 0.3×	52 1.6×	39	322
Kensuke Matsushita France	10	145 0.5×	63 0.6×	52 0.7×	7 0.2×	23 0.7×	32	349
Soraya El Ghannudi France	8	263 0.9×	134 1.3×	49 0.7×	10 0.2×	21 0.7×	17	297
B Goldberg South Africa	10	127 0.4×	87 0.8×	19 0.3×	36 0.8×	69 2.2×	29	320
Yuk–Kong Lau China	10	246 0.8×	133 1.3×	40 0.5×	88 2.0×	46 1.4×	11	376
Stuart J. Bresee United States	6	248 0.9×	136 1.3×	141 1.9×	41 1.0×	23 0.7×	8	336

Countries citing papers authored by I. Barazer

Since Specialization

Citations

This map shows the geographic impact of I. Barazer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by I. Barazer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites I. Barazer more than expected).

Fields of papers citing papers by I. Barazer

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by I. Barazer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by I. Barazer. The network helps show where I. Barazer may publish in the future.

Co-authorship network of co-authors of I. Barazer

This figure shows the co-authorship network connecting the top 25 collaborators of I. Barazer. A scholar is included among the top collaborators of I. Barazer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with I. Barazer. I. Barazer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

8 of 8 papers shown

Reny, Jean‐Luc, Philippe Berdagué, Antoine Poncet, et al.. (2012). Antiplatelet Drug Response Status Does Not Predict Recurrent Ischemic Events in Stable Cardiovascular Patients. Circulation. 125(25). 3201–3210. 66 indexed citations

Combescure, C., Pierre Fontana, Nora Mallouk, et al.. (2010). Clinical implications of clopidogrel non-response in cardiovascular patients: a systematic review and meta-analysis. Journal of Thrombosis and Haemostasis. 8(5). 923–933. 98 indexed citations

Fontana, Pierre, Philippe Berdagué, Christel Castelli, et al.. (2010). Clinical predictors of dual aspirin and clopidogrel poor responsiveness in stable cardiovascular patients from the ADRIE study. Journal of Thrombosis and Haemostasis. 8(12). 2614–2623. 61 indexed citations

Reny, Jean‐Luc, Robert F. Bonvini, I. Barazer, et al.. (2009). Le concept de « résistance » à l’aspirine : mécanismes et pertinence clinique. La Revue de Médecine Interne. 30(12). 1020–1029. 2 indexed citations

Reny, Jean‐Luc, et al.. (2008). Admission NT-proBNP levels, renal insufficiency and age as predictors of mortality in elderly patients hospitalized for acute dyspnea. European Journal of Internal Medicine. 20(1). 14–19. 11 indexed citations

Bargnoux, Anne‐Sophie, Kada Klouche, I. Barazer, et al.. (2008). Prohormone brain natriuretic peptide (proBNP), BNP and N-terminal-proBNP circulating levels in chronic hemodialysis patients. Correlation with ventricular function, fluid removal and effect of hemodiafiltration. Clinical Chemistry and Laboratory Medicine (CCLM). 46(7). 1019–24. 42 indexed citations

Pers, Yves‐Marie, et al.. (2008). Fièvre Q aiguë, antiphospholipides et thrombose artérielle rénale : à propos d’un cas et revue de la littérature. La Revue de Médecine Interne. 30(3). 250–254. 6 indexed citations

Berdagué, Philippe, et al.. (2006). Use of N-terminal prohormone brain natriuretic peptide assay for etiologic diagnosis of acute dyspnea in elderly patients. American Heart Journal. 151(3). 690–698. 45 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact